These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 22617423)

  • 1. HPV-16 E2 contributes to induction of HPV-16 late gene expression by inhibiting early polyadenylation.
    Johansson C; Somberg M; Li X; Backström Winquist E; Fay J; Ryan F; Pim D; Banks L; Schwartz S
    EMBO J; 2012 May; 31(14):3212-27. PubMed ID: 22617423
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of novel human papillomavirus type 16 late mRNAs in differentiated W12 cervical epithelial cells.
    Milligan SG; Veerapraditsin T; Ahamet B; Mole S; Graham SV
    Virology; 2007 Mar; 360(1):172-81. PubMed ID: 17098271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 57-nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and polypyrimidine tract binding protein.
    Zhao X; Oberg D; Rush M; Fay J; Lambkin H; Schwartz S
    J Virol; 2005 Apr; 79(7):4270-88. PubMed ID: 15767428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Papillomavirus E2 Regulates SRSF3 (SRp20) To Promote Capsid Protein Expression in Infected Differentiated Keratinocytes.
    Klymenko T; Hernandez-Lopez H; MacDonald AI; Bodily JM; Graham SV
    J Virol; 2016 May; 90(10):5047-58. PubMed ID: 26962216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A downstream polyadenylation element in human papillomavirus type 16 L2 encodes multiple GGG motifs and interacts with hnRNP H.
    Oberg D; Fay J; Lambkin H; Schwartz S
    J Virol; 2005 Jul; 79(14):9254-69. PubMed ID: 15994820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P53 represses human papillomavirus type 16 DNA replication via the viral E2 protein.
    Brown C; Kowalczyk AM; Taylor ER; Morgan IM; Gaston K
    Virol J; 2008 Jan; 5():5. PubMed ID: 18190682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A viral genome landscape of RNA polyadenylation from KSHV latent to lytic infection.
    Majerciak V; Ni T; Yang W; Meng B; Zhu J; Zheng ZM
    PLoS Pathog; 2013; 9(11):e1003749. PubMed ID: 24244170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Papillomavirus 16 (HPV16) E2 Repression of TWIST1 Transcription Is a Potential Mediator of HPV16 Cancer Outcomes.
    Fontan CT; Das D; Bristol ML; James CD; Wang X; Lohner H; Atfi A; Morgan IM
    mSphere; 2020 Dec; 5(6):. PubMed ID: 33298572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The E8--E2 gene product of human papillomavirus type 16 represses early transcription and replication but is dispensable for viral plasmid persistence in keratinocytes.
    Lace MJ; Anson JR; Thomas GS; Turek LP; Haugen TH
    J Virol; 2008 Nov; 82(21):10841-53. PubMed ID: 18753207
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth inhibition of HeLa cells is a conserved feature of high-risk human papillomavirus E8^E2C proteins and can also be achieved by an artificial repressor protein.
    Fertey J; Hurst J; Straub E; Schenker A; Iftner T; Stubenrauch F
    J Virol; 2011 Mar; 85(6):2918-26. PubMed ID: 21191025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus type 16 E2 and E6 are RNA-binding proteins and inhibit in vitro splicing of pre-mRNAs with suboptimal splice sites.
    Bodaghi S; Jia R; Zheng ZM
    Virology; 2009 Mar; 386(1):32-43. PubMed ID: 19187948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenovirus E4orf4 induces HPV-16 late L1 mRNA production.
    Somberg M; Rush M; Fay J; Ryan F; Lambkin H; Akusjärvi G; Schwartz S
    Virology; 2009 Jan; 383(2):279-90. PubMed ID: 19026433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulatory element in the 3'-untranslated region of human papillomavirus 16 inhibits expression by binding CUG-binding protein 1.
    Goraczniak R; Gunderson SI
    J Biol Chem; 2008 Jan; 283(4):2286-96. PubMed ID: 18042543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human papillomavirus type 16 L1 protein directly interacts with E2 and enhances E2-dependent replication and transcription activation.
    Siddiqa A; Léon KC; James CD; Bhatti MF; Roberts S; Parish JL
    J Gen Virol; 2015 Aug; 96(8):2274-2285. PubMed ID: 25911730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of senescence-like state and suppression of telomerase activity through inhibition of HPV E6/E7 gene expression in cells immortalized by HPV16 DNA.
    Lee CJ; Suh EJ; Kang HT; Im JS; Um SJ; Park JS; Hwang ES
    Exp Cell Res; 2002 Jul; 277(2):173-82. PubMed ID: 12083799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression.
    Rush M; Zhao X; Schwartz S
    J Virol; 2005 Sep; 79(18):12002-15. PubMed ID: 16140776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV-16 E2 physical status and molecular evolution in vivo in cervical carcinomas.
    Kahla S; Kochbati L; Chanoufi MB; Maalej M; Oueslati R
    Int J Biol Markers; 2014 Mar; 29(1):e78-85. PubMed ID: 24170557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of HPV-16 late L1 5'-splice site SD3632 by binding of hnRNP D proteins and hnRNP A2/B1 to upstream AUAGUA RNA motifs.
    Li X; Johansson C; Glahder J; Mossberg AK; Schwartz S
    Nucleic Acids Res; 2013 Dec; 41(22):10488-508. PubMed ID: 24013563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human Papillomavirus E6/E7 and Long Noncoding RNA TMPOP2 Mutually Upregulated Gene Expression in Cervical Cancer Cells.
    He H; Liu X; Liu Y; Zhang M; Lai Y; Hao Y; Wang Q; Shi D; Wang N; Luo XG; Ma W; Zhang TC
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30728257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.